Rextor Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Aurangabad, Maharashtra, India, established in 2016.
2016 Aurangabad, Maharashtra, India Active
Last Updated:
Access Report
About Rextor Pharmaceuticals Private Limited

Rextor Pharmaceuticals Private Limited, a active private limited company, was established on 19 September 2016 in Aurangabad, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2016PTC285997. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Dipak Ishwar Bainade (Director), Rohidas Sahebarav Ambhore (Director), Narayan Ishwarsingh Bainade (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at C/O Agaji Kisan Autade, Pap-08, Shendra Midc, Aurangabad, Maharashtra, 431001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2016PTC285997

  • Registration Number

    285997

  • Incorporation Date

    19 September 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** %
  • Profit Growth **** 40.48%
  • Ebitda **** 40.48%
  • Net Worth ****
  • Total Assets -23.01%
Company report

Rextor Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rextor Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rextor Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dipak Ishwar Bainade Director 01 Jan 2024 Current
Rohidas Sahebarav Ambhore Director 19 Sep 2016 Current
Narayan Ishwarsingh Bainade Director 19 Sep 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rextor Pharmaceuticals.

Rextor Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.48% increase in profit. The company's net worth witnessed no change by increase of 0%.

Rextor Pharmaceuticals revenue growth over time
Rextor Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -23.01%
*******
*******
*******
*******
Profit or Loss
*******
 40.48%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 40.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rextor Pharmaceuticals?

Unlock access to Rextor Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rextor Pharmaceuticals?

Unlock and access historical data on people associated with Rextor Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rextor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rextor Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rextor Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Dipak Ishwar Bainade was appointed as a Director was appointed as a Director on 01 Jan 2024 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

  • Annual General Meeting

    Rextor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Rextor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Rohidas Sahebarav Ambhore was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 9 years 4 months . was completed.

  • Director Appointment

    Narayan Ishwarsingh Bainade was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Rextor Pharmaceuticals Private Limited was registered on 19 Sep 2016 with Roc Mumbai & aged 9 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rextor Pharmaceuticals Private Limited?

The CIN of Rextor Pharmaceuticals Private Limited is U74999MH2016PTC285997.

Where is Rextor Pharmaceuticals Private Limited headquartered?

Rextor Pharmaceuticals Private Limited is headquartered at C/O Agaji Kisan Autade, Pap-08, Shendra Midc, Aurangabad, Maharashtra, 431001.

When was Rextor Pharmaceuticals Private Limited incorporated?

Rextor Pharmaceuticals Private Limited was incorporated on 19 September 2016.

Who are the current directors of Rextor Pharmaceuticals Private Limited?

The current directors of Rextor Pharmaceuticals Private Limited are

What is the primary industry of Rextor Pharmaceuticals Private Limited?

The primary industry of Rextor Pharmaceuticals Private Limited is Business Services.

Is Rextor Pharmaceuticals Private Limited a listed company?

Rextor Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rextor Pharmaceuticals Private Limited?

The authorized capital of Rextor Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Rextor Pharmaceuticals Private Limited?

The compliance status of Rextor Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available